The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to submit comments for the record on the hearing titled “Examining Implementation of the Biologics Price Competition and Innovation Act” scheduled for February 4, 2016.
The Academy of Managed Care Pharmacy (AMCP) commends the Obama Administration and the Centers for Medicare and Medicaid Services (CMS) for its support of Senator Pat Toomey’s (R-PA) leadership in addressing the opioid epidemic and S. 1913 - “The Stopping Medication Abuse and Protecting Seniors Act.”
The Academy of Managed Care Pharmacy (AMCP) is opposed to the Substitute for House Bill 4812 because the U.S. Food and Drug Administration (FDA) has not released guidance on how applicants can demonstrate interchangeability.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Disease Control and Prevention (CDC) for its work in developing strategies to address the growing opioid epidemic in the United States and for the opportunity to provide comments in response to the Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain (CDC-2015-0112).
The Academy of Managed Care Pharmacy (AMCP) is pleased to provide general comments and recommendations to the Call for Comments on Endorsement Consideration by PQA Members of a New Performance Measure: Adherence to Long-Acting Inhaled Bronchodilator Agents in COPD Patients.